RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      전이성 대장직장암 환자에서 Irinotecan, 5-Fluorouracil 및 Leucovorin을 병용한 항암화학요법(FOLFIRI)의 효과 = Effect of an? Irinotencan, 5-Fluorouracil, and Leucovorin Combination Chemotherapy (FOLFIRI) in Metastatic Colorectal Cancer

      한글로보기

      https://www.riss.kr/link?id=A104776245

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      참고문헌 (Reference)

      1 "plus fluorouracil and leucovorin for metastatic colorectal cancer" 343 : 905-914, 2000

      2 "Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer" 352 : 1407-1412, 1998

      3 "Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer" 352 : 1413-1418, 1998

      4 "Phase Ⅲ randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale" 23 : 4866-4875, 2005

      5 "Phase Ⅱ trial of irinotecan in patients with metastatic colorectal carcinoma" 15 : 2910-2919, 1997

      6 "Phase Ⅱ study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy" 36 : 235-239, 2004

      7 "Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy" 15 : 251-260, 1997

      8 "Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer" 14 : 1128-1135, 1996

      9 "Irinotecan is an active agent in untreated patients with metastatic colorectal cancer" 14 : 709-715, 1996

      10 "Irinotecan in the treatment of colorectal cancer: clinical overview" 19 : 1501-1518, 2001

      1 "plus fluorouracil and leucovorin for metastatic colorectal cancer" 343 : 905-914, 2000

      2 "Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer" 352 : 1407-1412, 1998

      3 "Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer" 352 : 1413-1418, 1998

      4 "Phase Ⅲ randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale" 23 : 4866-4875, 2005

      5 "Phase Ⅱ trial of irinotecan in patients with metastatic colorectal carcinoma" 15 : 2910-2919, 1997

      6 "Phase Ⅱ study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy" 36 : 235-239, 2004

      7 "Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy" 15 : 251-260, 1997

      8 "Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer" 14 : 1128-1135, 1996

      9 "Irinotecan is an active agent in untreated patients with metastatic colorectal cancer" 14 : 709-715, 1996

      10 "Irinotecan in the treatment of colorectal cancer: clinical overview" 19 : 1501-1518, 2001

      11 "Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial" 355 : 1041-1047, 2000

      12 "Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high- dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer" 17 : 2901-2908, 1999

      13 "Irinotecan combined with bolus fluorouracil and low-dose leucovorin every two weeks in patients with oxaliplatin pretreated metastatic colorectal cancer" 35 : 135-140, 2003

      14 "Combination chemotherapy of irinotecan combined with bolus 5-fluorouracil, continuous infusion 5-fluorouracil, and high dose leucovorin every two weeks in recurrent or metastatic colorectal cancer" 64 : 452-458, 2003

      15 "Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)" 35 : 54-59, 1999

      16 "CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer" 35 : 1343-1347, 1999

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-03-13 학술지명변경 한글명 : Journal of the Korean Society of Coloproctolgy -> Annals of Coloproctolgy
      외국어명 : Journal of the Korean Society of Coloproctolgy -> Annals of Coloproctolgy
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-11-26 학술지명변경 한글명 : 대한대장항문학회지 -> Journal of the Korean Society of Coloproctolgy KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-05-30 학술지등록 한글명 : 대한대장항문학회지
      외국어명 : 미등록
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.09 0.09 0.08
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.07 0.06 0.312 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼